IL100549A - Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleoside analogue and a derivative of a reductase inhibitory ribonucleotide peptide - Google Patents
Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleoside analogue and a derivative of a reductase inhibitory ribonucleotide peptideInfo
- Publication number
- IL100549A IL100549A IL10054991A IL10054991A IL100549A IL 100549 A IL100549 A IL 100549A IL 10054991 A IL10054991 A IL 10054991A IL 10054991 A IL10054991 A IL 10054991A IL 100549 A IL100549 A IL 100549A
- Authority
- IL
- Israel
- Prior art keywords
- asp
- tbg
- val
- cypn
- pyrrolidino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002033448A CA2033448C (en) | 1990-12-31 | 1990-12-31 | Antiherpes compositions and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
IL100549A0 IL100549A0 (en) | 1992-09-06 |
IL100549A true IL100549A (en) | 1995-11-27 |
Family
ID=4146737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10054991A IL100549A (en) | 1990-12-31 | 1991-12-30 | Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleoside analogue and a derivative of a reductase inhibitory ribonucleotide peptide |
Country Status (9)
Country | Link |
---|---|
US (1) | US5552384A (ja) |
EP (1) | EP0493770B1 (ja) |
JP (1) | JP3209552B2 (ja) |
AT (1) | ATE156362T1 (ja) |
AU (1) | AU648855B2 (ja) |
CA (1) | CA2033448C (ja) |
DE (1) | DE69127184T2 (ja) |
IL (1) | IL100549A (ja) |
NZ (1) | NZ241121A (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846941A (en) * | 1992-03-12 | 1998-12-08 | Boehringer Ingelheim (Canada) Ltd. | Isosteric antiherpes peptide derivatives II |
ES2152269T3 (es) * | 1993-03-03 | 2001-02-01 | Boehringer Ingelheim Ca Ltd | Inhibidores de ribonucleotido-reductasa de herpesvirus. |
CA2095408A1 (en) * | 1993-05-03 | 1994-11-04 | James Gus Chafouleas | Method of combating acyclovir-resistant herpes simplex viral infections |
US5459063A (en) * | 1993-10-14 | 1995-10-17 | The University Of Pennsylvania | Plasmodium falciparum ribonucleotide reductase DNA |
US6194143B1 (en) | 1996-12-27 | 2001-02-27 | Boehringer Ingelheim (Canada) Ltd. | Substrates for human cytomegalovirus protease |
JP4110347B2 (ja) * | 1999-11-05 | 2008-07-02 | 大鵬薬品工業株式会社 | 抗hiv剤 |
WO2011035120A2 (en) * | 2009-09-17 | 2011-03-24 | Gk Ventures, L.L.C. | Therapeutic composition to treat lesions caused by herpes simplex virus |
US8853223B2 (en) | 2010-09-17 | 2014-10-07 | G2L Touch, Inc. | Therapeutic composition to treat lesions caused by herpes simplex virus |
JP2014141475A (ja) * | 2012-12-27 | 2014-08-07 | Daiichi Sankyo Co Ltd | 新規美白剤 |
CN112996789A (zh) | 2018-09-12 | 2021-06-18 | 诺华股份有限公司 | 抗病毒吡啶并吡嗪二酮化合物 |
KR20220070005A (ko) | 2019-09-26 | 2022-05-27 | 노파르티스 아게 | 항바이러스성 피라졸로피리디논 화합물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795740A (en) * | 1986-05-20 | 1989-01-03 | Cohen Eric A | Antiviral peptides and means for treating herpes infections |
GB8815241D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Antiviral combinations & compounds therefor |
-
1990
- 1990-12-31 CA CA002033448A patent/CA2033448C/en not_active Expired - Fee Related
-
1991
- 1991-12-20 NZ NZ241121A patent/NZ241121A/xx unknown
- 1991-12-21 EP EP91122073A patent/EP0493770B1/en not_active Expired - Lifetime
- 1991-12-21 AT AT91122073T patent/ATE156362T1/de not_active IP Right Cessation
- 1991-12-21 DE DE69127184T patent/DE69127184T2/de not_active Expired - Fee Related
- 1991-12-26 JP JP34421791A patent/JP3209552B2/ja not_active Expired - Fee Related
- 1991-12-30 AU AU90093/91A patent/AU648855B2/en not_active Ceased
- 1991-12-30 IL IL10054991A patent/IL100549A/en not_active IP Right Cessation
-
1994
- 1994-06-06 US US08/254,391 patent/US5552384A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0493770B1 (en) | 1997-08-06 |
JPH04275229A (ja) | 1992-09-30 |
ATE156362T1 (de) | 1997-08-15 |
CA2033448C (en) | 1996-11-26 |
EP0493770A3 (en) | 1993-03-17 |
JP3209552B2 (ja) | 2001-09-17 |
DE69127184D1 (de) | 1997-09-11 |
AU648855B2 (en) | 1994-05-05 |
US5552384A (en) | 1996-09-03 |
EP0493770A2 (en) | 1992-07-08 |
IL100549A0 (en) | 1992-09-06 |
NZ241121A (en) | 1994-06-27 |
DE69127184T2 (de) | 1997-12-18 |
AU9009391A (en) | 1992-07-02 |
CA2033448A1 (en) | 1992-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2033448C (en) | Antiherpes compositions and method of use | |
US5484771A (en) | Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus | |
US5380727A (en) | Synergistic combination for treating herpes infections | |
CA1340681C (en) | Antiherpes tetrapeptides having a substituted aspartic acid side chain | |
US5700780A (en) | Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain | |
EP0411334B1 (en) | Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain | |
AU683450B2 (en) | Inhibitors of herpes viral ribonucleotide reductase | |
US5066783A (en) | Antiviral peptides and means for treating herpes infections | |
CA1340684C (en) | Antiherpes pentapeptides | |
CA1340683C (en) | Antiherpes pentapeptides having a substituted aspartic acid side chain | |
US5149778A (en) | Cyclic peptides for treating herpes infections | |
EP0560274B1 (en) | Antiherpes peptide derivatives having a ureido N-terminus | |
IL94982A (en) | History of herpes tetrapeptide with a side chain of converted aspartic acid in their preparation and pharmaceutical preparations containing | |
US5258493A (en) | Cyclic peptides for treating herpes infections | |
US5830864A (en) | Antiherpes peptide derivatives having a ureido n-terminus | |
CA2019005C (en) | Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
HP | Change in proprietorship | ||
KB | Patent renewed | ||
RH | Patent void | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |